SCHEMBL22063201

SCHEMBL22063201

CC(C)c1cc(-c2ccccc2)cc(-c2cc3c4c(c2)n2c5ccccc5nc2n4c2nc4ccccc4n32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CASR P41180 1/20 0.37
HSD17B10 Q99714 6/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
TYMS P04818 1/20 0.36
MAOA P21397 1/20 0.36
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TP53 P04637 3/20 0.35
LMNA P02545 3/20 0.35
GAA P10253 2/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
ADORA2A P29274 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063040 0.93 CASR (0.39) KDM4EHPGDALDH1A1CASRHSD17B10
SCHEMBL22062710 0.90 CASR (0.37) KDM4EHPGDALDH1A1CASRHSD17B10
SCHEMBL22062534 0.90 CASR (0.46) KDM4EHPGDALDH1A1CASRHSD17B10
SCHEMBL22063202 0.89 KDM4E (0.46) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL22063217 0.88 KDM4E (0.40) KDM4EHPGDCASRHSD17B10MEN1
SCHEMBL22062533 0.86 ALDH1A1 (0.44) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL22063050 0.86 ALDH1A1 (0.46) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL22087351 0.85 KDM4E (0.35) KDM4EHPGDALDH1A1CASRHSD17B10
SCHEMBL22063339 0.85 KDM4E (0.44) KDM4EHPGDALDH1A1HSD17B10MEN1
SCHEMBL22062529 0.84 KDM4E (0.39) KDM4EHPGDALDH1A1CASRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 KDM4E 1152/4885HPGD 4021/4885ALDH1A1 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.